FIELD: medicine.
SUBSTANCE: invention refers to a composition inhibiting norepinephrine and/or serotonin transporters containing (-) - [ (5-[3-methylaminoprop -(E)-ylidene] - 10, 11 -dihydro- 5H- dibenzo [a,d] cyclohepten-10-ol] in an enantiomeric residue about 90%, and its use for pain management.
EFFECT: higher clinical effectiveness.
12 cl, 21 ex
Authors
Dates
2012-12-20—Published
2008-04-22—Filed